Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Penzel

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
International Journal of Cancer|September 27, 2018
Identification of a highly lethal V3<sup>+</sup> TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinomaP Christopoulos, M Kirchner, F Bozorgmehr, et al.
Oncogene|October 30, 2013
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcomaM Trautmann, E Sievers, S Aretz, et al.
ESMO Open|September 6, 2021
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaM Kirchner, K Kluck, R Brandt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinomaS M Dieter, C Heining, A Agaimy, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencingP Christopoulos, M Kirchner, J Roeper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersA Jahn, A Rump, T J Widmann, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
International Journal of Cancer|September 27, 2018
Identification of a highly lethal V3<sup>+</sup> TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinomaP Christopoulos, M Kirchner, F Bozorgmehr, et al.
Oncogene|October 30, 2013
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcomaM Trautmann, E Sievers, S Aretz, et al.
ESMO Open|September 6, 2021
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaM Kirchner, K Kluck, R Brandt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinomaS M Dieter, C Heining, A Agaimy, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencingP Christopoulos, M Kirchner, J Roeper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersA Jahn, A Rump, T J Widmann, et al.
Pageof 4